Skip to content

Clinical trials

Phase 2 trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Unknown status Country / region: China Clear all

2,688 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20041
20051
20065
200712
200816
200934
201035
201157
201277
201380
201486
2015102
2016150
2017131
2018147
2019277
2020315
2021399
2022347
2023299
2024111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status2,688

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University193
Fudan University185
Tianjin Medical University Cancer Institute and Hospital85
Peking Union Medical College Hospital79
Chinese Academy of Medical Sciences72
Zhejiang Cancer Hospital72
Peking University42
Henan Cancer Hospital38
Peking University People's Hospital38
The First Affiliated Hospital with Nanjing Medical University35

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung207
Colorectal Neoplasms130
Breast Neoplasms128
Stomach Neoplasms127
Carcinoma, Hepatocellular107
Nasopharyngeal Carcinoma77
Esophageal Squamous Cell Carcinoma63
Small Cell Lung Carcinoma49
Recurrence48
Esophageal Neoplasms47

Trials

Showing 1 to 25 of 2,688. Each trial links to its page on Pharma Observatory.

2,588 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.